Real-world treatment patterns and clinical effectiveness outcomes of eribulin in metastatic breast cancer patients in community oncology centers in the United States

被引：0
|
作者：
Mougalian, S. S. [1 ]
Kish, J. K. [2 ]
Zhang, J. [3 ]
Miller, T. [2 ]
Liassou, D. [2 ]
Laney, J. [2 ]
Iyer, S. [3 ]
机构：
[1] Yale Med Sch, Yale Canc Ctr, Guilford, CT USA
[2] Cardinal Hlth, Real World Evidence & Insights, Dublin, OH USA
[3] Eisai Inc, US HEOR & RWE, Woodcliff Lake, NJ USA
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.annonc.2020.08.418
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
316P
引用
收藏
页码：S369 / S369
页数：1
相关论文
共 50 条
  • [1] Real-world treatment patterns and clinical effectiveness of eribulin in HR+/HER2-metastatic breast cancer patients in the United States
    Mougalian, S. S.
    Zhang, J.
    Kish, J. K.
    Zettler, M. E.
    Feinberg, B. A.
    ANNALS OF ONCOLOGY, 2021, 32 : S72 - S72
  • [2] Real-world clinical effectiveness of eribulin in metastatic breast cancer patients with visceral metastases in the United States.
    Mougalian, Sarah Schellhorn
    Zhang, Jingchuan
    Kish, Jonathan
    Zettler, Marjorie E.
    Feinberg, Bruce A.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [3] Effectiveness of Eribulin in Metastatic Breast Cancer: 10 Years of Real-World Clinical Experience in the United States
    Sarah S. Mougalian
    Jonathan K. Kish
    Jingchuan Zhang
    Djibril Liassou
    Bruce A. Feinberg
    Advances in Therapy, 2021, 38 : 2213 - 2225
  • [4] Effectiveness of Eribulin in Metastatic Breast Cancer: 10 Years of Real-World Clinical Experience in the United States
    Mougalian, Sarah S.
    Kish, Jonathan K.
    Zhang, Jingchuan
    Liassou, Djibril
    Feinberg, Bruce A.
    ADVANCES IN THERAPY, 2021, 38 (05) : 2213 - 2225
  • [5] Correction to: Effectiveness of Eribulin in Metastatic Breast Cancer: 10 Years of Real-World Clinical Experience in the United States
    Sarah S. Mougalian
    Jonathan K. Kish
    Jingchuan Zhang
    Djibril Liassou
    Bruce A. Feinberg
    Advances in Therapy, 2021, 38 : 2226 - 2228
  • [6] Correction to: Effectiveness of Eribulin in Metastatic Breast Cancer: 10 Years of Real-World Clinical Experience in the United States
    Sarah S. Mougalian
    Jonathan K. Kish
    Jingchuan Zhang
    Djibril Liassou
    Bruce A. Feinberg
    Advances in Therapy, 2021, 38 : 3487 - 3487
  • [7] Real-world treatment patterns and outcomes among elderly metastatic triple negative breast cancer patients in the United States
    Satram-Hoang, S.
    Bajaj, P.
    Stein, A.
    Hoang, K. Q.
    Momin, F.
    Cortazar, P.
    Reyes, C.
    ANNALS OF ONCOLOGY, 2017, 28
  • [8] Real-world treatment patterns and clinical outcomes in patients treated with eribulin after prior phosphoinositide 3-Kinase inhibitor treatment for metastatic breast cancer
    Ravi K. Goyal
    Jingchuan Zhang
    Keith L. Davis
    Martina Sluga-O’Callaghan
    Peter A. Kaufman
    Breast Cancer Research and Treatment, 2024, 205 : 201 - 210
  • [9] Effectiveness of Eribulin in Metastatic Breast Cancer: 10 Years of Real-World Clinical Experience in the United States (vol 38, pg 2213, 2021)
    Mougalian, Sarah S.
    Kish, Jonathan K.
    Zhang, Jingchuan
    Liassou, Djibril
    Feinberg, Bruce A.
    ADVANCES IN THERAPY, 2021, 38 (06) : 3487 - 3487
  • [10] Real-world treatment patterns and clinical outcomes in patients treated with eribulin after prior phosphoinositide 3-Kinase inhibitor treatment for metastatic breast cancer
    Goyal, Ravi K.
    Zhang, Jingchuan
    Davis, Keith L.
    Sluga-O'Callaghan, Martina
    Kaufman, Peter A.
    BREAST CANCER RESEARCH AND TREATMENT, 2024, 205 (01) : 201 - 210
12345